Pandemic School Closures Linked To More Mental Health Problems Among Kids

A large observational study of 185,700 California children aged 5–18 across 24 counties and 224 school districts found that staggered in-person school reopenings during March 2020–June 2021 were associated with substantially lower rates of pediatric mental-health diagnoses compared with prolonged closures. Reopening correlated with a 43% lower risk of a mental-health diagnosis and, by nine months, an 11% reduction in medical spending on student mental health, an 8% decline in psychiatric drug spending and a 5% drop in ADHD drug spending—effects that were stronger in girls—signaling that schools provide critical social, emotional and clinical supports and implying measurable impacts on pediatric care demand and education and health policy planning in future public-health emergencies.

Analysis

The Harvard T.H. Chan School of Public Health study published in Epidemiology analyzed health records for 185,700 children aged 5–18 across 24 California counties and 224 school districts from March 2020 to June 2021, using staggered in-person reopenings as a natural comparison. Aggregate pediatric mental-health diagnoses rose from 2.8% to 3.5% during the study window, yet children experienced a 43% lower risk of a mental-health diagnosis following school reopening versus the shutdown period.

By the ninth month after reopening, researchers observed an 11% decline in medical spending on student mental-health problems, an 8% drop in psychiatric drug spending and a 5% reduction in ADHD-specific drug spending; effects were stronger among girls. The analysis is based on utilization and prescription data (care received or prescriptions), which indicates measurable demand shifts rather than self-reported symptom change.

Investigators link benefits to restored social interaction, regular schedules, access to school-based mental-health supports and reduced household stressors, and they recommend prioritizing safe reopenings in future public-health emergencies. While the staggered reopening design strengthens inference, the study remains observational and subject to unmeasured confounding, so policymakers and market participants should treat results as a strong signal of policy-sensitive demand rather than definitive causation.

Key Decisions for Investors

• Monitor pediatric mental-health claim volumes and psychotropic prescription trends and adjust utilization and revenue forecasts for payers, PBMs and specialty pharmacies accordingly
• Incorporate school-reopening policy scenarios into financial models for healthcare and education-exposed assets, since reopenings were associated with sizable drops in utilization and spending
• Assess exposure to providers of school-based mental-health services and community pediatric behavioral-health programs as potential policy tailwinds or sources of volatility
• Segment forecasts by gender given stronger effects among girls and refine product and capacity planning for pediatric behavioral-health services and medications
• Maintain flexible allocations or hedges in positions tied to pediatric mental-health utilization because findings are observational and further causal confirmation would alter long-term demand assumptions